SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : BICO & VITK

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Terry D. who wrote (2287)3/29/1999 11:51:00 AM
From: James E Lynch  Read Replies (2) of 2395
 
(COMTEX) B: Biocontrol Delivers Diasensor 1000 to the FDA
B: Biocontrol Delivers Diasensor 1000 to the FDA

PITTSBURGH (March 29) BUSINESS WIRE -March 29, 1999--Biocontrol
Technology Inc. (OTC BB:BICO) announced today that a Diasensor 1000
Noninvasive Blood Glucose Monitor was delivered to the Food and Drug
Administration (FDA) following the conclusion of a technical seminar
presented to FDA staff members at the Company's Indiana, Pa.,
facilities on March 23 and 24, 1999.

The FDA purchased the Diasensor 1000, which is already approved for
sale in the 15-country European Union, in order to evaluate its
performance characteristics and conduct laboratory and clinical
research on noninvasive monitoring. The purpose of the seminar was to
educate the attending FDA staff members regarding the application,
operation and maintenance of the device. Biocontrol will continue to
assist the FDA, as requested, in their study of this new noninvasive
technology.

David L. Purdy, president of Biocontrol, stated, "The FDA personnel
who attended the seminar were very knowledgeable about existing
invasive glucose testing technology, and the Biocontrol presentation
was designed to extend FDA personnel's understanding of the Company's
noninvasive technology used in the Diasensor 1000. Both the FDA and
Biocontrol personnel profited from the interchange of concepts embodied
in the Diasensor."

Biocontrol Technology has its corporate offices in Pittsburgh, Pa.,
and is involved in the development and manufacture of biomedical
devices and environmental products. Biocontrol has the exclusive rights
to the research and development and manufacturing of the Diasensor
1000. Subsidiary Diasensor.com Inc., also located in Pittsburgh, Pa.,
owns the patent, marketing and distribution rights to the sensor. WEB
SITE: www.bico.com INVESTOR RELATIONS NEWSLINE NUMBER: 800/357-6204

-0- ec/sa*

CONTACT: Biocontrol Technology Inc., Pittsburgh
Investors: Diane McQuaide, 412/429-0673

or
Media: Susan Taylor, 412/429-0673

KEYWORD: PENNSYLVANIA
INDUSTRY KEYWORD: MEDICINE BIOTECHNOLOGY ENVIRONMENT ENMED PRODUCT
Today's News On The Net - Business Wire's full file on the Internet

with Hyperlinks to your home page.
URL: businesswire.com

*** end of story ***
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext